Nexalin Technology, Inc. (NXL)Healthcare | Medical Devices | Houston, United States | NasdaqCM
0.25 USD
0.00
(-1.884%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.27 +0.02 (7.160%) ⇧ (Aug. 28, 2026, 7:43 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 4:48 a.m. EDT
The immediate outlook is severely bearish as the stock trades significantly below its 50-day and 200-day moving averages, indicating heavy selling pressure and a lack of technical support. While the recent price action shows a flat, range-bound pattern rather than a violent crash, the underlying business fundamentals are deteriorating rapidly with revenue collapsing by over 80% and operating margins plunging into deep negative territory. This creates a dangerous divergence where the market is pricing in a potential value trap rather than a turnaround story. There is no dividend to provide a floor, and the balance sheet shows significant cash burn with no clear path to profitability. The statistical forecast suggests a slight upward lean, but given the low confidence and the stark fundamental deterioration, this technical signal is likely noise rather than a genuine reversal. Investors should view this as a high-risk speculative vehicle with no margin of safety. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.126191 |
| AutoETS | 0.127160 |
| AutoTheta | 0.127209 |
| MSTL | 0.166180 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 21% |
| H-stat | 16.70 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.007 |
| Excess Kurtosis | 1.13 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.011 |
| Market Cap | 213,878 |
| Forward P/E | -0.81 |
| Beta | 4.04 |
| Website | https://www.nexalin.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.72901165 |
| Address1 | 1,776 Yorktown |
| Address2 | Suite 550 |
| All Time High | 4.49 |
| All Time Low | 0.22 |
| Ask | 0.3264 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 226,720 |
| Average Daily Volume3 Month | 240,914 |
| Average Volume | 240,914 |
| Average Volume10Days | 226,720 |
| Beta | 4.037 |
| Bid | 0.175 |
| Bid Size | 2 |
| Book Value | 0.069 |
| City | Houston |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.25 |
| Current Ratio | 1.254 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 0.2596 |
| Day Low | 0.25 |
| Display Name | Nexalin Technology |
| Ebitda | -9,080,485 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.508 |
| Enterprise To Revenue | 21.229 |
| Enterprise Value | 4,609,917 |
| Eps Current Year | -0.38 |
| Eps Forward | -0.31 |
| Eps Trailing Twelve Months | -0.46 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.37498 |
| Fifty Day Average Change | -0.12498 |
| Fifty Day Average Change Percent | -0.3332978 |
| Fifty Two Week Change Percent | -72.90117 |
| Fifty Two Week High | 2.0 |
| Fifty Two Week High Change | -1.75 |
| Fifty Two Week High Change Percent | -0.875 |
| Fifty Two Week Low | 0.22 |
| Fifty Two Week Low Change | 0.030000001 |
| Fifty Two Week Low Change Percent | 0.13636364 |
| Fifty Two Week Range | 0.22 - 2.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,663,335,000,000 |
| Float Shares | 19,316,008 |
| Forward Eps | -0.31 |
| Forward P E | -0.8064516 |
| Free Cashflow | -2,533,424 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 8 |
| Fullday Change | -0.00479999 |
| Fullday Change Percent | -1.88383 |
| Fullday Price | 0.2679 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.86157995 |
| Gross Profits | 187,097 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0929 |
| Held Percent Institutions | 0.03452 |
| Implied Shares Outstanding | 855,514 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas. |
| Long Name | Nexalin Technology, Inc. |
| Market | us_market |
| Market Cap | 213,878 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1763227626 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -8,988,864 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 6,542,119 |
| Number Of Analyst Opinions | 1 |
| Open | 0.255 |
| Operating Cashflow | -6,128,895 |
| Operating Margins | -184.79689 |
| Payout Ratio | 0.0 |
| Phone | 832 260 0222 |
| Post Market Change | 0.01789999 |
| Post Market Change Percent | 7.159996 |
| Post Market Price | 0.2679 |
| Post Market Time | 1,787,960,595 |
| Previous Close | 0.2548 |
| Price Eps Current Year | -0.65789473 |
| Price Hint | 4 |
| Price To Book | 3.6231885 |
| Price To Sales Trailing12 Months | 0.9849094 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.712 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.00479999 |
| Regular Market Change Percent | -1.88383 |
| Regular Market Day High | 0.2596 |
| Regular Market Day Low | 0.25 |
| Regular Market Day Range | 0.25 - 0.2596 |
| Regular Market Open | 0.255 |
| Regular Market Previous Close | 0.2548 |
| Regular Market Price | 0.25 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 209,412 |
| Return On Assets | -1.19224 |
| Return On Equity | -2.40253 |
| Revenue Growth | -0.828 |
| Revenue Per Share | 0.011 |
| Sand P52 Week Change | 0.1966995 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 855,514 |
| Shares Percent Shares Out | 0.0152 |
| Shares Short | 342,208 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 654,993 |
| Short Name | Nexalin Technology, Inc. |
| Short Percent Of Float | 0.015700001 |
| Short Ratio | 1.71 |
| Source Interval | 15 |
| State | TX |
| Symbol | NXL |
| Target High Price | 2.0 |
| Target Low Price | 2.0 |
| Target Mean Price | 2.0 |
| Target Median Price | 2.0 |
| Total Cash | 1,004,958 |
| Total Cash Per Share | 0.046 |
| Total Debt | 0 |
| Total Revenue | 217,155 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.46 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.533035 |
| Two Hundred Day Average Change | -0.28303498 |
| Two Hundred Day Average Change Percent | -0.5309876 |
| Type Disp | Equity |
| Volume | 209,412 |
| Website | https://www.nexalin.com |
| Zip | 77,056 |